Published in Br J Ophthalmol on May 01, 1998
Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol (1989) 6.53
Psychophysical evidence for separate channels for the perception of form, color, movement, and depth. J Neurosci (1987) 3.88
Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol (1993) 3.42
Larger optic nerve heads have more nerve fibers in normal monkey eyes. Arch Ophthalmol (1991) 2.38
Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci (1987) 2.31
Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol (1980) 2.28
Ways of measuring rates of recurrent events. BMJ (1996) 2.18
Accounting for the correlation between fellow eyes in regression analysis. Arch Ophthalmol (1992) 1.72
Retinal ganglion cell classes in the Old World monkey: morphology and central projections. Science (1981) 1.70
Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol (1993) 1.24
Optic disc morphometry in chronic primary open-angle glaucoma. II. Correlation of the intrapapillary morphometric data to visual field indices. Graefes Arch Clin Exp Ophthalmol (1988) 1.13
Neuron loss in the aging visual cortex of man. J Gerontol (1980) 1.09
Motion perception is abnormal in primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci (1990) 1.05
Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results. Arch Ophthalmol (1995) 1.01
Sensitivity and specificity of optic disc parameters in chronic glaucoma. Invest Ophthalmol Vis Sci (1993) 0.93
Retinal potentials in patients with primary open-angle glaucoma: physiological evidence for temporal frequency tuning deficits. Invest Ophthalmol Vis Sci (1985) 0.86
Visual field screening and the development of a new screening program. J Am Optom Assoc (1989) 0.79
High-tech advances in the treatment of chronic cancer pain. Caring (1989) 0.78
Profile of patients presenting for cataract surgery in the UK: national data collection. Br J Ophthalmol (1999) 6.69
National cataract surgery survey 1997-8: a report of the results of the clinical outcomes. Br J Ophthalmol (1999) 4.65
The deficit in cataract surgery in England and Wales and the escalating problem of visual impairment: epidemiological modelling of the population dynamics of cataract. Br J Ophthalmol (2000) 4.18
A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry (1995) 3.65
Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol (1996) 3.52
Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol (1993) 3.42
Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond) (2010) 3.26
Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomised trial. Br J Ophthalmol (2001) 2.98
Deprivation and late presentation of glaucoma: case-control study. BMJ (2001) 2.86
Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol (1996) 2.81
Gains from cataract surgery: visual function and quality of life. Br J Ophthalmol (1996) 2.38
The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess (2007) 2.27
Causes of blind certifications in England and Wales: April 1999-March 2000. Eye (Lond) (2007) 2.11
BD8 certification of visually impaired people. Br J Ophthalmol (1998) 1.96
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Ther (2008) 1.88
Chronic glaucoma in northern Ghana--a retrospective study of 397 patients. Eye (Lond) (1990) 1.88
Risk factors for development of post-trabeculectomy endophthalmitis. Br J Ophthalmol (2000) 1.72
Prevalence of diabetic macular oedema and related health and social care resource use in England. Br J Ophthalmol (2011) 1.60
Who should see eye casualties?: a comparison of eye care in an accident and emergency department with a dedicated eye casualty. J Accid Emerg Med (1995) 1.56
Journals and the Internet. Use of the Internet for on line peer review must be explored further. BMJ (1997) 1.51
Time to look again at sight tests. BMJ (1997) 1.47
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Ther (2008) 1.41
Surgical interventions for age-related cataract. Cochrane Database Syst Rev (2006) 1.41
Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev (2005) 1.41
What's in a name? New glaucoma drugs. Lancet (2006) 1.40
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene Ther (2009) 1.40
Risk factors for late presentation in chronic glaucoma. Invest Ophthalmol Vis Sci (1999) 1.36
Evidence of genetic resistance of cattle to infection with Mycobacterium bovis. J Dairy Sci (2010) 1.32
Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev (2008) 1.30
Detection and prevention of treatable visual failure in general practice: room for improvement? Br J Gen Pract (1994) 1.28
Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med (2000) 1.27
Registration of blind and partially sighted people. Br J Ophthalmol (1994) 1.23
Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest (1996) 1.22
Retinal vascular network architecture in low-birth-weight men. J Hypertens (1997) 1.15
Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry (2006) 1.12
Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. Br J Ophthalmol (2005) 1.09
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene Ther (2012) 1.08
Screening for prevention of optic nerve damage due to chronic open angle glaucoma. Cochrane Database Syst Rev (2006) 1.08
Enhancement of seed oil content by expression of glycerol-3-phosphate acyltransferase genes. Biochem Soc Trans (2000) 1.07
Community ophthalmology pilot study. Eye (Lond) (1993) 1.06
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma. Oncogene (2011) 1.04
Laser trabeculoplasty for open angle glaucoma. Cochrane Database Syst Rev (2007) 1.04
Evaluation of ophthalmoscopy by nonophthalmologists in diagnosing chronic glaucoma in West Africa. Eye (Lond) (1989) 1.03
Retrospective analysis of risk factors for late presentation of chronic glaucoma. Br J Ophthalmol (1999) 1.02
The role of Hispanic race/ethnicity and poverty in breast cancer survival. P R Health Sci J (1995) 0.99
The Peterborough scheme for community specialist optometrists in glaucoma: a feasibility study. Eye (Lond) (2010) 0.96
Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol (1993) 0.96
Cataract surgery--quantity and quality. Br J Ophthalmol (1999) 0.95
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer. Cell Death Dis (2013) 0.95
A prospective study to identify high-yield criteria associated with acute intracranial computed tomography findings in head-injured patients. Am J Emerg Med (1993) 0.94
Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK. Br J Ophthalmol (2000) 0.93
Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr (1993) 0.93
Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships. Hypertension (1995) 0.92
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. Int J Cancer (2013) 0.90
Ivermectin for onchocercal eye disease (river blindness). Cochrane Database Syst Rev (2001) 0.89
The primary treatment trial: changes in the visual field analysis by computer-assisted perimetry. Eye (Lond) (1994) 0.88
Visual acuity and its relationship to early growth, eye disease, and aging in north Hertfordshire. Ophthalmic Epidemiol (1998) 0.87
Genetic parameters for production, health, fertility and longevity traits in dairy cows. Animal (2012) 0.87
Childbearing and risk of cataract in young women: an epidemiological study in central India. Br J Ophthalmol (2002) 0.87
Causes of certifications for severe sight impairment (blind) and sight impairment (partial sight) in children in England and Wales. Br J Ophthalmol (2013) 0.86
Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense. Hypertension (1997) 0.86
Why involve consumers in eye health research? Eye (Lond) (2011) 0.86
Organochlorine chemicals in tree swallows nesting in pool 15 of the Upper Mississippi River. Bull Environ Contam Toxicol (2000) 0.86
Recovery: what mental health nurses and service users say about the concept of recovery. J Psychiatr Ment Health Nurs (2011) 0.85
Appropriate technology for cataract surgery. Lancet (1998) 0.85
The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003. Br J Ophthalmol (2006) 0.85
Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev (2001) 0.84
Neutrophils from AIDS patients treated with granulocyte colony-stimulating factor demonstrate enhanced killing of Mycobacterium avium. J Infect Dis (1998) 0.84
Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia. J Med Genet (2006) 0.83
Nutrition and the epidemiology of cataract and age-related maculopathy. Eur J Clin Nutr (1994) 0.83
Effects of nasal airflow on breathing during sleep in normal humans. Am Rev Respir Dis (1993) 0.83
Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis (1987) 0.83
Radiation to control transgene expression in tumors. Cancer Biol Ther (2007) 0.82
Breeding and Genetics Symposium: really big data: processing and analysis of very large data sets. J Anim Sci (2011) 0.82
Mid-infrared prediction of bovine milk fatty acids across multiple breeds, production systems, and countries. J Dairy Sci (2011) 0.82
Cystic fibrosis in adolescents and adults. Ir Med J (1992) 0.82
Role of leukotrienes in antimicrobial defense of the lung. J Lab Clin Med (1998) 0.82
Persistency with medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994-2005. Eye (Lond) (2008) 0.81
Eye care utilisation patterns in a rural county in Ireland: implications for service delivery. Br J Ophthalmol (1997) 0.81
The EORTC clinical research coordinators group. European Organisation for Research and Treatment of Cancer. Eur J Cancer (2002) 0.81
Do selective topical beta antagonists for glaucoma have respiratory side effects? Br J Ophthalmol (2004) 0.80
A chest radiograph scoring system in adult cystic fibrosis: correlation with pulmonary function. Clin Radiol (1991) 0.80
A new health technology: where is the consensus on a clinically worthwhile benefit? Eye (Lond) (2002) 0.80
Introduction of photodynamic therapy for the treatment of neovascular age-related macular degeneration: tracking a moving target. Eye (Lond) (2003) 0.80
Unmet needs for cataract surgery in Spain according to indication criteria. Evaluation through a simulation model. Br J Ophthalmol (2008) 0.79
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo. Clin Exp Immunol (2015) 0.78
Evidence based medicine, the Cochrane Collaboration, and the CONSORT statement. Br J Ophthalmol (1998) 0.78
Role of leukotrienes in antimicrobial host defense of the lung. Clin Rev Allergy Immunol (1999) 0.78
Cystic fibrosis in adolescents and adults. Ir Med J (1991) 0.78
Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. Psychopharmacol Bull (1988) 0.78
Joint estimation of genetic parameters for test-day somatic cell count and mastitis in the United Kingdom. J Dairy Sci (2012) 0.77
Pregnancy in women with Type 1 and Type 2 diabetes in Dublin. Ir J Med Sci (2011) 0.77
Pulsed low dose rate brachytherapy in a rat model: dependence of late rectal injury on radiation pulse size. Int J Radiat Oncol Biol Phys (1997) 0.77
Short communication: genetic relationships between the Holstein cow populations of three European dairy countries. J Dairy Sci (2009) 0.77
Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour. Br J Ophthalmol (1998) 0.76
Mid-infrared prediction of lactoferrin content in bovine milk: potential indicator of mastitis. Animal (2012) 0.76
Understanding the genetics of survival in dairy cows. J Dairy Sci (2013) 0.76